Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Current Liabilities -----

What is the latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is - based on Mar2025 Consolidated results.
Year Current Liabilities
Mar2025-
Mar2024-
Mar2023-
Mar2022-
Mar2017-

How is Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Current Liabilities % Change
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2017 - -

Compare Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,235.2 Cr -0.4% -7.8% -28.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-0.4%

-7.8%

-28.5%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses